Breast cancer screening
Breast cancer screening is a vital part of early detection and improved survival. From a oncoplastic and reconstructive breast surgery perspective, screening not only identifies cancers at an earlier stage but also increases the likelihood of less extensive surgery and better cosmetic outcomes. Detecting breast cancer before it causes symptoms allows treatment to be more effective and, in many cases, less invasive.
What is breast cancer screening?
Breast cancer screening involves testing women who do not have symptoms to detect early signs of cancer. The main screening test is mammography, which uses low-dose X-rays to identify abnormalities in breast tissue.
Screening aims to detect cancers when they are small and confined to the breast. At this stage, treatment is generally more straightforward, and long-term outcomes are significantly improved.
Women aged 50 to 71 in the UK are routinely invited for screening every three years. Some women outside this age group may be offered screening based on individual risk factors, such as a strong family history of breast cancer or known genetic mutations.
Why is early detection so important?
Early detection plays a crucial role in surgical planning and overall treatment success. When breast cancer is identified at an early stage:
- The tumour is often smaller
- Lymph node involvement is less likely
- Breast-conserving surgery may be possible
- The need for more aggressive treatments may be reduced
- Survival rates are significantly higher
From an oncoplastic perspective, smaller tumours increase the likelihood of preserving the breast while achieving safe cancer clearance. This allows the use of advanced reconstructive techniques to maintain breast shape and symmetry.
What happens if a screening mammogram shows an abnormality?
An abnormal screening result does not necessarily mean cancer is present. Many findings are benign, such as cysts or harmless calcifications.
If an abnormality is detected, further assessment is arranged. This may include:
- Additional mammographic views
- Breast ultrasound
- MRI in selected cases
- Image-guided biopsy
A biopsy provides a definitive diagnosis by analysing tissue under a microscope. This information guides treatment decisions and surgical planning.
How does screening influence surgical options?
When cancer is detected early through screening, more conservative surgical options are often available.
These may include:
- Breast-conserving surgery combined with reshaping techniques
- Therapeutic mammoplasty to remove cancer while lifting and reshaping the breast
- Sentinel lymph node biopsy rather than full node clearance
- Immediate reconstruction if mastectomy is required
Oncoplastic techniques combine cancer surgery with plastic surgery principles. This approach ensures complete tumour removal while aiming to achieve the best possible cosmetic result.
Early diagnosis expands the range of reconstructive options and may reduce the need for complex procedures later.
Are there limitations to breast cancer screening?
Screening is highly effective but not perfect. Some cancers may not be visible on mammography, particularly in women with dense breast tissue. Occasionally, screening detects slow-growing cancers that may never have caused harm, a concept known as overdiagnosis.
Despite these limitations, the benefits of screening in reducing breast cancer mortality are well established.
What should women consider about breast screening?
Breast cancer screening remains one of the most effective tools for early detection. Regular attendance at screening appointments, awareness of breast changes, and prompt assessment of any new symptoms are essential.
From a surgical perspective, early diagnosis allows safer cancer treatment, more conservative surgery, and improved reconstructive outcomes. Screening not only saves lives but also enhances the quality of surgical care and long-term wellbeing.
